GB201320053D0 - Therapeutic canine immunoglobulins and methods of using the same - Google Patents
Therapeutic canine immunoglobulins and methods of using the sameInfo
- Publication number
- GB201320053D0 GB201320053D0 GBGB1320053.0A GB201320053A GB201320053D0 GB 201320053 D0 GB201320053 D0 GB 201320053D0 GB 201320053 A GB201320053 A GB 201320053A GB 201320053 D0 GB201320053 D0 GB 201320053D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- methods
- same
- canine immunoglobulins
- therapeutic canine
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000282465 Canis Species 0.000 title 1
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
- 229940072221 immunoglobulins Drugs 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
- C07K16/467—Igs with modifications in the FR-residues only
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161483481P | 2011-05-06 | 2011-05-06 | |
GBGB1114858.2A GB201114858D0 (en) | 2011-08-29 | 2011-08-29 | Anti-nerve growth factor antibodies and methods of using the same |
US201161531439P | 2011-09-06 | 2011-09-06 | |
PCT/GB2012/051008 WO2012153126A1 (en) | 2011-05-06 | 2012-05-08 | Therapeutic canine immunoglobulins and methods of using the same |
Publications (4)
Publication Number | Publication Date |
---|---|
GB201320053D0 true GB201320053D0 (en) | 2013-12-25 |
GB2504889A GB2504889A (en) | 2014-02-12 |
GB2504889B GB2504889B (en) | 2015-07-15 |
GB2504889C GB2504889C (en) | 2015-08-26 |
Family
ID=49818570
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1320045.6A Active GB2505352B (en) | 2011-05-06 | 2012-05-08 | Anti-nerve growth factor antibodies and methods of preparing and using the same |
GB1320053.0A Active GB2504889C (en) | 2011-05-06 | 2012-05-08 | Therapeutic canine immunoglobulins and methods of using the same |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1320045.6A Active GB2505352B (en) | 2011-05-06 | 2012-05-08 | Anti-nerve growth factor antibodies and methods of preparing and using the same |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB2505352B (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001253282A1 (en) * | 2000-04-07 | 2001-10-23 | Heska Corporation | Compositions and methods related to canine igg and canine il-13 receptors |
EP1485126A4 (en) * | 2001-12-21 | 2007-03-21 | Idexx Lab Inc | Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
ITRM20030601A1 (en) * | 2003-12-24 | 2005-06-25 | Lay Line Genomics Spa | METHOD FOR THE HUMANIZATION OF HUMANIZED ANTIBODIES AND ANTIBODIES WITH IT OBTAINED. |
US8569460B2 (en) * | 2009-03-25 | 2013-10-29 | Vet Therapeutics, Inc. | Antibody constant domain regions and uses thereof |
WO2010117448A2 (en) * | 2009-04-05 | 2010-10-14 | Provenance Biopharmaceuticals Corp. | Chimeric immunocytokines and methods of use thereof |
AU2011291462A1 (en) * | 2010-08-19 | 2013-03-14 | Zoetis Belgium S.A. | Anti-NGF antibodies and their use |
-
2012
- 2012-05-08 GB GB1320045.6A patent/GB2505352B/en active Active
- 2012-05-08 GB GB1320053.0A patent/GB2504889C/en active Active
Also Published As
Publication number | Publication date |
---|---|
GB2504889C (en) | 2015-08-26 |
GB2505352A (en) | 2014-02-26 |
GB2504889B (en) | 2015-07-15 |
GB2504889A (en) | 2014-02-12 |
GB201320045D0 (en) | 2013-12-25 |
GB2505352B (en) | 2016-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201607259TA (en) | Therapeutic canine immunoglobulins and methods of using the same | |
EP2739144A4 (en) | Compounds and therapeutic uses thereof | |
IL229254A0 (en) | Therapeutic antibodies | |
SG11201403834QA (en) | Combination therapy of antibodies against human csf-1r and uses thereof | |
IL221288A0 (en) | Therapeutic methods using anti-cd200 antibodies | |
EP2621499A4 (en) | Methods for the treatment of allergic diseases | |
ZA201403760B (en) | Anti-cd98 antibodies and methods of use thereof | |
IL232055B (en) | Anti-htra1 antibodies and methods of use | |
ZA201403372B (en) | Therapeutic agents and uses thereof | |
GB201207599D0 (en) | Transistor and the method of manufacture | |
PT2757878E (en) | Method for the preparation and improvement of horseshoes | |
EP2825199A4 (en) | Human autotaxin antibodies and methods of use | |
PL2555790T3 (en) | THERAPEUTIC USE OF THE ß2-MICROGLOBULIN PROTEIN | |
GB2504889B (en) | Therapeutic canine immunoglobulins and methods of using the same | |
HK1195572A (en) | Therapeutic canine immunoglobulins and methods of using the same | |
HUE037704T2 (en) | Herbicidal composition and method of using the same | |
ZA201308992B (en) | Therapeutic antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S117 | Correction of errors in patents and applications (sect. 117/patents act 1977) |
Free format text: REQUEST FILED; REQUEST FOR CORRECTION UNDER SECTION 117 FILED ON 27 AUGUST 2015 |
|
S117 | Correction of errors in patents and applications (sect. 117/patents act 1977) |
Free format text: REQUEST FOR CORRECTION UNDER SECTION 117 FILED ON 27 AUGUST 2015, WITHDRAWN ON 01 FEBRUARY 2016 |
|
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) |
Free format text: REGISTERED BETWEEN 20160519 AND 20160525 |
|
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) |
Free format text: REGISTERED BETWEEN 20220609 AND 20220615 |